Kolumne, ORE

Original-Research: q.beyond AG - from NuWays AG Classification of NuWays AG to q.beyond AG Company Name: q.beyond AG ISIN: DE0005137004 Reason for the research: Update Recommendation: Kaufen from: 14.05.2024 Target price: EUR 1.10 Target price on sight of: 12 Monaten Last rating change: Analyst: Philipp Sennewald Strong Q1 figures hint towards successful transformation / chg.

14.05.2024 - 09:01:36

Original-Research: q.beyond AG (von NuWays AG): Kaufen


Original-Research: q.beyond AG - from NuWays AG

Classification of NuWays AG to q.beyond AG

Company Name: q.beyond AG
ISIN: DE0005137004

Reason for the research: Update
Recommendation: Kaufen
from: 14.05.2024
Target price: EUR 1.10
Target price on sight of: 12 Monaten
Last rating change: 
Analyst: Philipp Sennewald

Strong Q1 figures hint towards successful transformation/ chg.
 
Yesterday, q.beyond released a strong set of Q1 figures, which exceeded
ours and streets profitability estimates as efficiency measures bore fruit
despite rather muted top-line growth. In detail:
 
Q1 sales increased slightly by 1.1% yoy to EUR 47.1m (eNuW: EUR47.5m, eCons: EUR
47.6m), of which 74% were recurring revenues. The muted growth momentum was
predominantly due to the Consulting segment, which declined by 8% yoy to EUR
14.2m, which was mainly due to the reduction in low-margin project sales.
This also allowed for an improved segment gross margin (+6.3pp to 8.4%). In
the mid-term, management aims to continuously improve the Consulting margin
driven among others by an increasing offand near-shoring ratio (target: 20%
vs 12% after Q1), an improved utilizitation rate as well as higher daily
rates. In contrast, the Managed Services segment grew by 5.7% yoy to EUR
32.9m at an improved margin of 21.5%. Hence, q.beyond was able to improve
its gross profit by 38.5% to EUR 8.2m (eNuW: EUR 7.8m, eCons: EUR 7.9m), implying
a margin of 17.5% (+4.7pp yoy).
 
On this basis, Q1 EBITDA also significantly improved to EUR 2.0m at an
implied margin of 4.2% (eNuW: EUR 1.4m, eCons: EUR 1.4m), which compares to
negative EUR 1.3m in the previous year's quarter. Next to the improved gross
margin, EBITDA was driven by significantly reduced sales & marketing
(-1.5pp yoy sales ratio) and G&A expenses (-0.3pp) as well as the effects
of "One q.beyond" strategy (i.e. eliminating duplicate structures). FCF
came in at EUR 1.4m (company definition: EUR 0.6m), leading to a continuously
comfortable net cash position of 
You can download the research here:
http://www.more-ir.de/d/29737.pdf
For additional information visit our website
www.nuways-ag.com/research.

Contact for questions
NuWays AG  - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------transmitted by EQS Group AG.-------------------


The issuer is solely responsible for the content of this research.
The result of this research does not constitute investment advice
or an invitation to conclude certain stock exchange transactions.

@ dpa.de

Weitere Meldungen

Original-Research: Aroundtown SA (von First Berlin Equity Research GmbH): Kaufen Original-Research: Aroundtown SA - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Aroundtown SA Company Name: Aroundtown SA ISIN: LU1673108939 Reason for the research: Dreimonatsbericht Recommendation: Kaufen from: 30.05.2024 Target price: EUR3,50 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu Aroundtown SA (ISIN: LU1673108939) veröffentlicht. (Boerse, 30.05.2024 - 13:41) weiterlesen...

Original-Research: UBM Development AG (von NuWays AG): Kaufen Original-Research: UBM Development AG - from NuWays AG Classification of NuWays AG to UBM Development AG Company Name: UBM Development AG ISIN: AT0000815402 Reason for the research: Update Recommendation: Kaufen from: 30.05.2024 Target price: EUR 27.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Philipp Sennewald Market reopening still pending / chg. (Boerse, 30.05.2024 - 09:01) weiterlesen...

Original-Research: Enapter AG (von First Berlin Equity Research GmbH): Buy Original-Research: Enapter AG - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Enapter AG Unternehmen: Enapter AG ISIN: DE000A255G02 Anlass der Studie: Update Empfehlung: Buy seit: 29.05.2024 Kursziel: 11,00 Euro Kursziel auf Sicht von: 12 Monate Letzte Ratingänderung: 12.08.2021: Hochstufung von Hinzufügen auf Kaufen Analyst: Dr. (Boerse, 29.05.2024 - 15:11) weiterlesen...

Original-Research: Energy S.p.A. (von GBC AG): Kaufen Original-Research: Energy S.p.A. - von GBC AG Einstufung von GBC AG zu Energy S.p.A. Unternehmen: Energy S.p.A. ISIN: IT0005500712 Anlass der Studie: Researchstudie (Note) Empfehlung: Kaufen Kursziel: 2,75 EUR Letzte Ratingänderung: Analyst: Marcel Goldmann, Cosmin Filker Zuschlag für die Lieferung von XL-Speichersystemen und Services im Volumen von rund 26,0 Mio. (Boerse, 29.05.2024 - 10:31) weiterlesen...

Original-Research: CEWE Stiftung & Co. KGaA (von Montega AG): Kaufen. KGaA - von Montega AG Einstufung von Montega AG zu CEWE Stiftung & Co. Original-Research: CEWE Stiftung & Co. (Boerse, 28.05.2024 - 12:01) weiterlesen...

Original-Research: Delticom AG (von Montega AG): Kaufen Original-Research: Delticom AG - von Montega AG Einstufung von Montega AG zu Delticom AG Unternehmen: Delticom AG ISIN: DE0005146807 Anlass der Studie: Update Empfehlung: Kaufen seit: 28.05.2024 Kursziel: 5,50 EUR Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Bastian Brach Roadshow-Feedback: Mittelfristige Ambitionen rücken in den Fokus Wir haben am vergangenen Donnerstag gemeinsam mit Delticom in Person von CEO Dr. (Boerse, 28.05.2024 - 11:26) weiterlesen...